menu
    • menu

    Company profile for Nordic Nanovector

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodg...
    Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nordic NanovectorNorway Flag
    Country
    Country
    Norway
    Address
    Address
    Kjelsåsveien 168 B 0884 Oslo
    Telephone
    Telephone
    +47 22 18 33 01
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nordicnanovector.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nordic-nanovector-as
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nordic Nanovector announces agreement to acquire Thor Medical
    Nordic Nanovector announces agreement to acquire Thor Medical

    06 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nordic-nanovector-announces-agreement-to-acquire-thor-medical-an-emerging-producer-of-alpha-emitters-for-radiopharmaceuticals-to-treat-cancer-301844111.html

    PR NEWSWIRE
    06 Jun 2023
    Share Share
    NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED
    NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED

    31 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nordic-nanovector--annual-general-meeting-postponed-301786771.html

    PR NEWSWIRE
    31 Mar 2023
    Share Share
    Invitation to Second Half and Full Year 2022 Results Presentation and Webcast
    Invitation to Second Half and Full Year 2022 Results Presentation and Webcast

    21 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nordic-nanovector-asa-invitation-to-second-half-and-full-year-2022-results-presentation-and-webcast-301751575.html

    PR NEWSWIRE
    21 Feb 2023
    Share Share
    Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 Jan 2023
    Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 Jan 2023

    13 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nordic-nanovector-asa---notice-of-extraordinary-general-meeting-on-3-january-2023-301701373.html

    PRNEWSWIRE
    13 Dec 2022
    Share Share
    Nordic Nanovector faces board walkout after failed APIM merger
    Nordic Nanovector faces board walkout after failed APIM merger

    13 Dec 2022

    // James Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/nordic-nanovector-scrambles-recruit-new-directors-ceo-after-mass-boardroom-walkout-wake

    James Waldron FIERCEBIOTECH
    13 Dec 2022
    Share Share
    Nordic Nanovector update shareholder vote against merger with APIM
    Nordic Nanovector update shareholder vote against merger with APIM

    09 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nordic-nanovector-update-following-shareholder-vote-against-proposed-merger-with-apim-therapeutics-301699485.html

    PRNEWSWIRE
    09 Dec 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search